DYRK1A inhibitors as therapeutic approach to TAU hyper-phosphorylation for treatment of alzheimer disease and other CNS disorders
Ended Project Grant Awarded Last action
- Award ID
- R43AG063560
- Recipient
-
Avanti Biosciences, Inc. UEI GZNJSM9ELXB3
- Awarding agency
-
National Institute on Aging
National Institutes of Health, Department of Health and Human Services
- Obligated
- $448,597
Award facts
- Assistance listing
- 93.866 Aging Research
- Completion date
- Originally
- Place of performance
- California, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$420 | |
| Amendment | -$420 | |
| Original award | $449,436 |
Quick answers
Who received award R43AG063560?
R43AG063560 was awarded to Avanti Biosciences, Inc. by National Institute on Aging (National Institutes of Health) on July 1, 2019.
How much is award R43AG063560 worth?
$448,597 has been obligated on R43AG063560.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award